InsidersTradesSigma
Explore the detailed record of transactions filed by Dudley Robert Michael, Chief Executive Officer. Director active across 1 company, notably Transcode Therapeutics, Inc.. Aggregated, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €48k. History available since 27 May 2022. The latest transaction was disclosed on 27 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Robert Michael Dudley is the Chief Executive Officer of Transcode Therapeutics, Inc. He oversees the company's operations and is responsible for implementing the development strategy. His expertise in the biopharmaceutical field enables him to lead innovative projects and promote research and development.